在马拉维怀孕期间治疗贫血的静脉铁治疗的看法和经验:形成性的定性研究
Lucinda Manda-Taylor1, Macdonald Kufankomwe1, Gertrude Chatha1
1School of Global and Public Health, Kamuzu University of Health Sciencies, Private Bag 360, Blantyre, 3, Malawi.
Gates open research
|March 8, 2024
概括
在马拉维,尽管存在文化问题,静脉注射 (IV) 铁是可以接受的,用于治疗怀孕期间的贫血. 患者教育团体可以帮助解决更广泛使用的障碍.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 怀孕期间的贫血是全球重要的健康问题.
- 静脉注射 (IV) 铁是治疗缺铁性贫血 (IDA) 的有效方法.
- 了解患者和医疗保健提供者的观点对于成功实施新疗法至关重要.
研究的目的:
- 在马拉维探索IV铁治疗妊娠贫血的可接受性.
- 确定马拉维医疗保健系统中引入IV铁的障碍和促进因素.
主要方法:
- 15次与孕妇进行深入采访.
- 2重点小组与孕妇进行讨论.
- 7对卫生工作者进行深入采访.
- 在马拉维的Blantyre和Zomba进行的研究.
主要成果:
- 孕妇报告说,用静脉注射铁感觉更好,更强壮,认为它比口服铁更快.
- 关于IV铁的文化信仰和误解是接受性的障碍.
- 卫生工作者发现静脉注射铁很容易使用,但对成本和培训需求表示担忧.
结论:
- 在马拉维,尽管最初存在担忧,但IV铁输注是可以接受的,用于治疗怀孕期间的IDA.
- 参与者倡导小组可以促进社区教育和解决问题.
- 将静脉注射铁纳入日常护理需要解决成本和培训问题.
相关概念视频
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
154
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
154
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K